Tag archive for ‘an-Fite BioPharma Ltd. (TASE:CFBI’
Globes On Wednesday, July 3rd, 2013

Ophthalix Files Preliminary Prospectus in New York for IPO

– Can-Fite Eye Disease spin-off hopes to raise up to US$10 million on NYSE. Road show starts in July.   – Can-Fite CEO Pnina Fishman – / By Gali Weinreb / Can-Fite BioPharma Ltd. (TASE:CFBI; More...

Wordpress site Developed by Fixing WordPress Problems